Cited by 2,772Sepsis Diagnosis and TreatmentInflammation biomarkers and pathwaysImmune Response and Inflammation

Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy

Open access
Hotchkiss, Richard S., Monneret, Guillaume, Payen, Didier·2013·Nature Reviews Immunology

Abstract

Sepsis - which is a severe life-threatening infection with organ dysfunction - initiates a complex interplay of host pro-inflammatory and anti-inflammatory processes. Sepsis can be considered a race to the death between the pathogens and the host immune system, and it is the proper balance between the often competing pro- and anti-inflammatory pathways that determines the fate of the individual. Although the field of sepsis research has witnessed the failure of many highly touted clinical trials, a better understanding of the pathophysiological basis of the disorder and the mechanisms responsible for the associated pro- and anti-inflammatory responses provides a novel approach for treating this highly lethal condition. Biomarker-guided immunotherapy that is administered to patients at the proper immune phase of sepsis is potentially a major advance in the treatment of sepsis and in the field of infectious disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nri3552

Cites

174 of 174 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Sepsis has often been considered as a syndrome evolving from an initial state of systemic and hypermetabolic inflammation into a more protracted phase of immunosuppression, characterized by lymphocyte exhaustion and apoptosis, diminished capacity of monocytes and macrophages to release pro-inflammatory cytokines, and occurrence of secondary infections.

    “From a pathophysiological perspective, sepsis has often been considered as a syndrome evolving from an initial state of systemic and hypermetabolic inflammation into a more protracted phase of immunosuppression, characterized by lymphocyte exhaustion and apoptosis, diminished capacity of monocytes and macrophages to release pro-inflammatory cytokines, and occurrence of secondary infections [1].”

    From Nutrition in Sepsis: A Bench-to-Bedside Review. (2020) · cites this paper as [1]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 1

  1. [80]van Dissel JT van Langevelde P Westendorp RG Kwappenberg K Frolich M Anti-inflammatory cytokine profile and mortality in febrile patients Lancet 351 950 3 1998 9734942

Cited by

Sorted by citations

Authors
Hotchkiss, R. S., Monneret, G., & Payen, D.
Affiliations
  • Washington University in St. Louis (US)
  • Hospices Civils de Lyon (FR)
  • Assistance Publique – Hôpitaux de Paris (FR)
Corresponding author
Hotchkiss, Richard S.
Venue
Nature Reviews Immunology
Published
2013-11-15
Volume
13
Issue
12
Pages
862-874
ISSN
  • 1474-1733 (ISSN-L)
  • 1474-1741
OpenAlex
W2083513831
Cited by
2,772
References
174
Citations by year
2026: 364 · 2025: 277 · 2024: 241 · 2023: 227 · 2022: 239 · 2021: 286 · 2020: 227 · 2019: 220 · 2018: 178 · 2017: 199 · 2016: 147 · 2015: 101 · 2014: 62 · 2013: 1 · 2012: 2
FWCI
12.16
Type
journal article
Language
en
Open access
Locations
  • Nature reviews. Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • University of Washington
  • Hospices Civils de Lyon
  • National Institutes of Health (GM44118)
  • National Cancer Institute (P30CA091842)
  • National Institute of General Medical Sciences (GM55194, R01GM055194, R37GM044118, R01GM098391, R01GM044118, GM 44118)
Topics
  • Health Sciences › Medicine › Epidemiology › Sepsis Diagnosis and Treatment
  • Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Keywords
sepsis, sepsis-induced immunosuppression, immunotherapy, cellular dysfunction, hyperinflammation, biomarker-guided therapy, host immune response, organ dysfunction, intensive care
MeSH terms
Animals, Humans, Immune Tolerance, Immunity, Cellular, Immunity, Innate, Immunotherapy, Inflammation, Sepsis, Models, Animal, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review